Deep Brain Stimulation for the Treatment of Traumatic Brain Injury

Status Completed

Clinical Trial Summary

This study involves the treatment of cognitive impairment secondary to moderate to severe brain injury using central thalamic deep brain stimulation. Although all patients will receive stimulation continuously through a surgically implanted pacemaker-like device, half of the patients will have the device deactivated during a blinded assessment phase. The device will be reactivated following this assessment and patients will have the option to continue stimulation in an open-label continuation.

Clinical Trial Description

This preliminary safety study evaluates the use of the Medtronic Activa PC+S system and Medtronic Nexus-E system for central thalamic deep brain stimulation (CT-DBS) in the treatment of cognitive impairment secondary to traumatic brain injury (TBI). It involves a neurosurgical procedure in which electrodes are implanted in the brain, connected to an implanted pacemaker-like device in the chest. The proposed study, if successful, will provide supporting evidence for the development of a novel therapeutic approach utilizing CT-DBS to improve these enduring cognitive impairments arising in persons with multi-focal structural brain injuries. This research will address the critical gap of the lack of any available treatments. CT-DBS targets well-defined neuronal populations within the central thalamus that have known anatomical and physiological specializations, which not only provide a key role in arousal regulation during cognitively-mediated behaviors, but also exhibit a particular vulnerability to dysfunction in the setting of multi-focal, non-selective brain injuries. Our proposed study aims to support development of CT-DBS as a novel therapeutic avenue for accessing cognitive reserve in patients with acquired brain injuries. In the proposed feasibility study of 6 subjects at a single investigational site, we will test the safety of CT-DBS in the severe traumatic brain injury (STBI) population with GOSE 6-7 level recovery and collect data to establish the translation of preclinical studies into human application of CT-DBS. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02881151
Study type	Interventional
Source	Stanford University
Contact
Status	Completed
Phase	N/A
Start date	April 20, 2017
Completion date	May 4, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04526639` - VR Cognitive Rehabiliation for Pediatric TBI	N/A
Recruiting	`NCT05943756` - Evaluation of Well-being Interventions in Adults With TBI	N/A
Completed	`NCT01339702` - The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Completed	`NCT00760734` - Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD)	Phase 1
Not yet recruiting	`NCT06024122` - Brain Development in Young Children Following Mild Traumatic Brain Injury - Pilot Study
Completed	`NCT03896789` - Pediatric Guideline Adherence and Outcomes- Argentina	N/A
Completed	`NCT03225768` - Guided Training for People With Cognitive Impairment	N/A
Completed	`NCT04590911` - Effectiveness of Multimodal Cognitive Rehabilitation for Traumatic Brain Injury Sustained During Older Adulthood	N/A
Recruiting	`NCT04121780` - Growth Hormone Replacement Therapy for Retried Professional Football Players	Phase 2
Completed	`NCT04776304` - Art Therapy qEEG Study for Service Members With a Traumatic Brain Injury and Posttraumatic Stress Symptoms	N/A
Completed	`NCT00409058` - Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI	N/A
Completed	`NCT00205491` - Pharmacological Intervention in Depression After Traumatic Brain Injury	Phase 4
Completed	`NCT03490110` - Brain Markers of Improvements in Cognitive Functioning	N/A
Active, not recruiting	`NCT02525432` - Autologous Stem Cell Study for Adult TBI (Phase 2b)	Phase 2
Completed	`NCT02858544` - Concussion in Motor Vehicle Accidents: The Concussion Identification Index	N/A
Completed	`NCT01728831` - Study of Cerebral Tissue Oxygenation During Transfusion in Traumatic Brain Injury	N/A
Recruiting	`NCT06005194` - InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI	N/A
Not yet recruiting	`NCT05340803` - Sedation of Ventilated Traumatic Brain Injury Patients With Midazolam Alone Versus Combination With Dexmedetomidine or Magnesium Sulfate; Monitored by Ultrasonograghic Optic Nerve Sheath Diameter	Phase 3
Recruiting	`NCT06195345` - Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
Recruiting	`NCT04279431` - Follow-up of mTBI Patients Discharged From the ED Using Standard Clinical Triage Including BrainScope One

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.